Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Dosage Form Design Parameters: Volume II
    Unavailable
    Dosage Form Design Parameters: Volume II
    Unavailable
    Dosage Form Design Parameters: Volume II
    Ebook1,861 pages45 hours

    Dosage Form Design Parameters: Volume II

    By Academic Press

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Dosage Form Design Parameters, Volume II, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of dosage form design parameters. Chapters delve into a particular aspect of this fundamental field, covering principles, methodologies and the technologies employed by pharmaceutical scientists. In addition, the book contains a comprehensive examination suitable for researchers and advanced students working in pharmaceuticals, cosmetics, biotechnology and related industries.

    • Examines the history and recent developments in drug dosage forms for pharmaceutical sciences
    • Focuses on physicochemical aspects, prefomulation solid state properties and polymorphism
    • Contains extensive references for further discovery and learning that are appropriate for advanced undergraduates, graduate students and those interested in drug dosage design
    LanguageEnglish
    PublisherAcademic Press
    Release dateJul 25, 2018
    ISBN9780128144220
    Unavailable
    Dosage Form Design Parameters: Volume II

    Related to Dosage Form Design Parameters

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Tested and True

      Mar 10, 2023

      Tested and True
      2 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      Opening The ‘Black Box,’ Google DeepMind AI System Diagnoses Eye Diseases And Shows Its Work

      Aug 13, 2018

      Experts said the level of accuracy is impressive, but the bigger breakthrough is the DeepMind system’s solution to the so-called “black box” problem of artificial intelligence.

      5 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Printing Drugs Would Ease Burden of Multiple Pills a Day

      Sep 29, 2017

      A new technology can print pure, precisely customized doses of drugs. The technology could enable on-site printing of custom-dosed medications at pharmacies, hospitals, and other locations. “A doctor or pharmacist can choose any number of medications

      3 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Pill Board

      Jan 15, 2022

      Suppliers in India: N/A  Drug Type: Anti-viral Approval: In process, decision awaited Included in MoHFW guidelines: No Starting price: N/A Efficacy: Results from Phase II and III clinical trials showed it reduced risk of hospitalisation or death by 8

      1 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Opinion: Improving The Next Generation Of Drugs Through Patient-centric Design For Clinical Trials

      Dec 26, 2019

      In developing cancer drugs, the focus has been on eradicating cancer cells and shrinking tumors. It's time to also focus on patient factors like tolerability, ease of use, compliance with…

      3 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      Opinion: The Emergence Of Laboratory Benefits Managers: PBM Déjà Vu?

      Nov 5, 2019

      If left to develop unmonitored, as happened with PBMs, laboratory benefits managers could worsen rather than ease issues related to health care costs and utilization without improving outcomes.

      4 min read

    • Article

      Home Run

      Mar 25, 2022

      Home Run
      5 min read

    • Article

      Opinion: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks

      Jan 18, 2019

      It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks.

      5 min read

    Reviews for Dosage Form Design Parameters

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words